OxThera Company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Founded Date:
2005
Total Funding:
€4.9M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Late Stage Venture
Technology:
Others
Last Funding Type:
Seed
Investors Number:
10
Industry:
PharmTech
Headquarters:
Stockholm, Stockholms Lan, Sweden
Estimated Revenue:
$10M to $50M